Construction of a human monoclonal antibody against bFGF for suppression of NSCLC

Compelling evidence implicates that overexpression of basic fibroblast growth factor (bFGF) and fibroblast growth factor receptor 1 (FGFR1) in non-small cell lung cancer (NSCLC) drives tumor progression, can serve as prognostic biomarkers or therapeutic targets for NSCLC patients. But at present, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Sheng, Qin, Yiyang, Wang, Zhongmin, Xiang, Junjian, Zhang, Yu, Xu, Meng, Li, Baiyong, Xia, Yu, Zhang, Peng, Wang, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5995934/
https://www.ncbi.nlm.nih.gov/pubmed/29896285
http://dx.doi.org/10.7150/jca.24255

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5995934/
https://www.ncbi.nlm.nih.gov/pubmed/29896285
http://dx.doi.org/10.7150/jca.24255

Ejemplares similares